Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15319677 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Safety and Efficacy of Two Once Daily Anti Retroviral Treatment Regimens Along With Anti-tuberculosis Treatment
Conditions: Tuberculosis;   Human Immunodeficiency Virus Infections
Interventions: Drug: Didanosine, Lamivudine, Efavirenz;   Drug: Didanosine, Lamivudine, Nevirapine

Indicates status has not been verified in more than two years